Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Rosetta Genomics Ltd. (ROSG) Starts Presentation at the Aegis Healthcare Conference

Rosetta Genomics Ltd. develops diagnostic tools for microRNAs, a group of genes produced using instructions encoded in DNA. The company offers diagnostic tests, including miRview mets2, a microRNA-based diagnostic used to identify 42 tumor types including carcinomas, soft tissue tumors, lymphoma, and other malignancies; and miRview meso used to differentiate mesothelioma, a cancer connected to asbestos exposure and other risk factors, from other carcinomas in the lung and pleura. For more information, visit the company’s website at

This entry was posted in Aegis Conference. Bookmark the permalink.

Comments are closed.